Yuji Tokunaga

Statistics

Publications

Citations

1.9K

H-Index

Active since

1977

Affiliations

National Institute of Advanced Industrial Science and Technology(Current)

The University of Tokyo

Mochida Pharmaceutical (Japan)

Japan Biological Informatics Consortium

Fujisawa City Hospital

Yuji Tokunaga is an author at National Institute of Advanced Industrial Science and Technology specializing in pharmacy, drug delivery, and pharmacology.

ORCID

Publications per year

1977–2023

Publications

Establishment of new preparation method for solid dispersion formulation of tacrolimus

Kazunari Yamashita, Toshiomi Nakate, Kazuto Okimoto et al. · International Journal of Pharmaceutics · 2003 · 346 citations

Pharmacy, Pharmaceutics, Pharmacology +11

Reduced expression of <i>nm</i>23‐H1, but not of <i>nm</i>23‐H2, is concordant with the frequency of lymph‐node metastasis of human breast cancer

Yuji Tokunaga, Takeshi Urano, Koichi Furukawa et al. · International Journal of Cancer · 1993 · 121 citations

Medicine, Molecular Biology, Oncology +17

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto et al. · Journal of Controlled Release · 2006 · 93 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto et al. · Journal of Controlled Release · 2005 · 77 citations

Pharmacy, Pharmaceutics, Pharmacology +16

Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)

Hideki Hirabayashi, Toshiya Takahashi, Jiro Fujisaki et al. · Journal of Controlled Release · 2001 · 75 citations

Pharmacy, Pharmaceutics, Pharmacology +12

1–5 of 47